The Board also took note of the resignation tendered by Arijit Mukherjee, Whole Time Director who has stepped down from the position of “Whole Time Director” of the Company from July 28, 2021, while continuing to be the “Chief Operating Officer”of the Company.
Anurag Roy, aged 47 years, has over 21 years’ experience working in leading pharmaceuticals / chemicals Companies such as DSM, Dr. Reddy’s Labs, BASF and Jubilant Life Sciences.
He has proven track record of delivering commercial and operational excellence and leading several manufacturing, supply sites and CMOs. He joins Astec LifeSciences Limited from Navin Fluorine International Ltd. / Manchester Organics wherein he was working as COO - CRAMS, Pharmaceuticals.
He was responsible for P&L to manage and grow the global contract development & manufacturing business with global footprints (UK, Japan, USA) and GMP manufacturing in India. He was also responsible for building the customer base and global teams and introduce newer technology / capability enhancement by setting in-house capabilities or CMOs to cater to drug development pipelines of innovators.
He has previously worked with RPG Cables, India as a technical Engineer, from May 1996 to May 1998. He was a Global Consulting Director at Frost & Sullivan/ORC Int., USA, from May 2000 to February 2007.
Global Strategy Manager at BASF, USA & Germany, from March 2007 to February 2010. Further he was the Vice President & Business Head at Dr. Reddy’s Labs., India from July 2013 to Sept 2015. He was also the Vice President at CMOs & Ventures: Pharma APIs (DSM Affiliate)from March 2017 to May 2018. He was also the Managing Director (Board Member & Part of Global Executive Committee) at DSM from October 2015 to March 2017.
Anurag Roy has MBA- Executive, Columbia Business School, New York, USA. He has completed his Masters in International Business from Indian Institute of Foreign Trade, India and B. Tech, Chemicals (Polymers) from Harcourt Butler Technological Institute in India.
At around 10:05 AM, Astec Lifesciences was trading at Rs1,339.35 per piece down by Rs58.1 or 4.16% on Sensex.